MeichenbaumDTurkDC: Facilitating Treatment Adherence. New York, NY, Plenum Press, 1987.
2.
ErakerSAKirschtJPBeckerMH:Understanding and improving patient compliance. Ann Intern Med100:258–268,1984.
3.
KusserowRP: Medication regimens: Causes of noncompliance. Office of Inspector General, Department of Health and Human Services, Report OEI-0489–89121, 1990.
4.
BondWSHussarDA:Detection methods and strategies for improving medication compliance. Am J Hosp Pharm48:1978–1988,1991.
5.
Noncompliance with medication: An economic tragedy with important implications for health care reform: A report by the task force for compliance. Baltimore, MD, COMSORT, 1993.
6.
HerrierRNBoyceRW:Compliance with prescribed drug regimens, in BresslerRKatzM (eds): Geriatric Pharmacology. New York, NY, McGraw-Hill, 1993, pp 63–77.
7.
BresslerDA:Communicating with patients about their medications. N Engl J Med325:1650–1651,1991 (editorial).
8.
The Role of the Pharmacist in Comprehensive Medication Use Management. Washington, DC, American Pharmaceutical Association, 1992.
9.
OBRA 90: A Practical Guide to Effecting Pharmaceutical Care. Washington, DC, American Pharmaceutical Association, 1994.
10.
KingK:Strategies for enhancing compliance in the dialysis elderly. Am J Kidney Dis16:351–353,1990.
11.
PortnoyE: Enhancing communication with elderly patients. Am PharmNS25:506–511, 1985.
12.
WeingartenMA:Age as a major factor affecting adherence to medication for hypertension in a general medical population. Fam Pract5:294–296,1988.
13.
MurrayMBirtJManatungaADarnellJ:Medication compliance in elderly outpatients using twice daily dosing and unit of use packaging. Ann Pharmacother27:616–621,1993.
14.
WallstenSSullivanRHanlonJ:Medication taking behaviors in the high and low functioning elderly: MacArthur field studies of successful aging. Ann Pharmacother29:359–363,1995.
15.
StammWEHootenTM:Management of urinary tract infections in adults. N Engl J Med329:1328–1334,1993.
16.
BainJMurphyERossF:Acute otitis media: Clinical course among children who received a short course of high dose antibiotic. BMJ Clin Res Ed291:1243–1246,1985.
17.
ReefSEMcNeilMMSobelJD:Vulvovaginal candidiasis: Available therapeutic options. Infect Dis Clin Pract4:36–40,1995.
18.
Veterans Administration Cooperative Study on Antihypertensive Agents: Effects of treatment on morbidity: Results in patients with diastolic blood pressures averaging 115–129 mm Hg. JAMA202:1028–1034, 1967.
19.
TaguchiJFriesED:Partial versus complete control in the prevention of hypertensive complications. Circ Res36:257–260,1975.
20.
UrquhartJ:Role of patient compliance in clinical pharmacokinetics: A review of recent research. Clin Pharmacokinet27:202–215,1994.
21.
SbarbaroJASbarbaroJB:Compliance and supervision of chemotherapy of tuberculosis. Semin Respir Infect9:120–127,1994.
22.
AndradeSEWalkerAMGottlierLK:Discontinuation of antihyperlipidemic drugs: Do rates reported in clinical trials reflect rates in primary care settings?N Engl J Med332:1125–1131,1995.
23.
ColemanVR:Physician behavior and compliance. J Hypertens3:69–71,1985.
24.
SbarbaroJA:The patient physician relationship: Compliance revisited. Ann Allergy64:325–331,1990.
25.
SteeleDJBlackwellBGutmannMC:Beyond advocacy: A review of the active patient concept. Patient Educ Counsel10:3–23,1987.
26.
RowanKDHooverDM: Communicating risk to patients: Detecting, diagnosing and overcoming lay theories. USP Open Conference, Communicating Risk to Patients, Proceedings, 1995, pp 74–81.
27.
BaumannLLeventhalH: “I can tell when my blood pressure is up, can't I.”Health Psych4:203–218, 1985.
28.
CialdiniRB: Influence, The Psychology of Persuasion. New York, NY, Quill, 1993.
29.
RoterDLHallJA: Doctors Talking with Patients, Patients Talking with Doctors: Improving Communication in Medical Visits. Westport, CT, Auburn House, 1992.
30.
HerrierRNBoyceRWApgarDA:Pharmacist-managed patient-care services and prescriptive authority in the U.S. Public Health Service. Hosp Form25:67–80,1990.
31.
BorgsdorfLRMianoJSKnappKK:Pharmacist managed medication reviews in a managed care system. Am J Hosp Pharm51:772–777,1994.
32.
AndersonRM:Is the problem of noncompliance all in our heads?Diabetes Educ11:31–34,1985.
33.
HerrierRNBoyceRW: Establishing an active patient partnership. Am PharmNS35:48–59, 1995.
34.
BeckerMH:Patient adherence to prescribed therapies. Med Care23:539–555,1985.
35.
Pharmacist-Patient Consultation Program, (PPCP Unit1): An interactive approach to verify patient understanding. New York, NY, Pfizer Inc, 1991.
36.
MullenPDGreenLW:Meta-analysis points the way towards more effective patient education. Promoting Health6:6–8,1985.
37.
De TullioPLErakerSAJepsonC:Patient medication instructions and provider interactions: Effects on knowledge and attitude. Health Ed Q13:51–60,1986.
38.
JohnsonMVVMitchWESherwoodJ:The effect of a drug information sheet on understanding and attitude of patients about drugs. JAMA256:2722–2724,1986.
39.
MorrowDLeiverVSheikhJ:Adherence and medication instructions: Review and recommendations. J Am Geriatr Soc36:1147–1160,1988.
40.
HerrierRNBoyceRW: Obtaining and using patient data. Am PharmNS31:517–523, 1991.
41.
Pharmacist-Patient Consultation Program, (PPCP Unit 2): How to counsel patients in challenging situations. New York, NY, Pfizer Inc, 1993.
42.
Pharmacist-Patient Consultation Program, (PPCP Unit 3): Counseling to enhance compliance. New York, NY, Pfizer Inc, 1995.
43.
CameronRBestJA:Promoting adherence to health behavior change interventions. Patient Educ Counsel10:139–154,1987.
44.
AryDVToobertDWilsonWGlasgowRE:Patient perspective on factors contributing to non adherence to diabetes regimens. Diabetes Care9:168–172,1986.
45.
GagnonMCoteJMilotJ:Comparative safety and efficacy of single or twice daily administration of inhaled beclomethasone in moderate asthma. Chest105:1732–1737,1994.
46.
EisenSAMillerDKWoowardRS:The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med150:1881–1884,1990.
47.
SramekJJCutlerNRSeifertRD:Compliance in hypertension: Daily v twice daily. Am J Hypertens6:1063,1993.
48.
KubackaRTJuhlRF:Attitudes of patients with hypertension or arthritis towards the frequency of medication administration. Am J Hosp Pharm42:2400–2501,1985.
49.
KassMAMeltzerDGordonM:Compliance with topical pilocarpine. Am J Ophthalmol101:515–523,1986.
50.
KassMAGordonMMorleyRE:Compliance with topical timolol treatment. Am J Ophthalmol103:188–193,1987.
51.
ClarkLT:Improving compliance and increasing control of hypertension: Needs of special populations. Am Heart J121:664–669,1991.
52.
ColNFanaleJEKronholmP:The role of medication compliance and adverse drug reactions in hospitalization of the elderly. Arch Intern Med150:841–845,1990.
53.
HaynesRBSackettDLTaylorDW:Practical management of low compliance with antihypertensive therapy: A guide for the busy practitioner. Clin Invest Med1:175–180,1979.
54.
HaynesRBWangEDe MotaGomes M:A critical review of interventions to improve compliance with prescribed medication. Patient Educ Counsel10:155–166,1987.
55.
DohertyWJSchrottHGMetcalfL:Effect of spouse support and health beliefs on medication adherence. J Fam Pract17:837–841,1983.
56.
JanzNKBeckerMHHartmanPE:Contingency contracting to improve patient compliance: A review. Patient Educ Counsel5:165–178,1982.